Drug rashes can be an unwanted side effect of many medications. Learn which medications can cause these skin reactions.

The trial is structured to assess the safety and efficacy of the therapy in approximately 50 ATTRv-PN subjects.

The RSUs are subject to the terms and conditions of BioCryst's Inducement Equity Incentive Plan and a restricted stock unit ...

Hair dyes can be an exciting way to refresh your look, but understanding their risks ensures you make informed beauty choices ...

Mike Patterson, Curium's North American Chief Executive Officer said: “Customers are looking to simplify their business. Our generic version of DTPA allows Curium to offer a more comprehensive list of ...

This important study shows, for the first time, the structure and snapshots of the dynamics of the full-length soluble Angiotensin-I converting enzyme dimer. The combination of structural and ...

Pharvaris (PHVS) announced that the European Commission has granted orphan designation to its investigational drug, deucrictibant, for the ...

Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases ...

The Real Housewives of Beverly Hills alum is coping with facial disfigurement — which she suspects is caused by facial ...

Intellia Therapeutics, Inc. NTLA is developing its lead CRISPR-based, in vivo genome-editing candidate, nexiguran ziclumeran (nex-z, formerly known as NTLA-2001) for the treatment of transthyretin ...

Cycle Pharmaceuticals Limited (Cycle) is pleased to announce that Cycle Vita is now available with BAFIERTAM, expanding its patient support services in MS, following the acquisition of Banner Life ...

Cycle Pharmaceuticals Limited (Cycle) is pleased to announce that Cycle Vita is now available with BAFIERTAM, expanding its patient support services in MS, following the acquisition of Banner Life ...